-
1
-
-
68949220302
-
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study
-
Arsenault, B. J., Lemieux, I., Despres, J. P., Gagnon, P., Wareham, N. J., Stroes, E. S., et al. (2009). HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis 206, 276-281. doi: 10.1016/j.atherosclerosis.2009.01.044
-
(2009)
Atherosclerosis
, vol.206
, pp. 276-281
-
-
Arsenault, B.J.1
Lemieux, I.2
Despres, J.P.3
Gagnon, P.4
Wareham, N.J.5
Stroes, E.S.6
-
2
-
-
0038300497
-
Change in alpha1 HDL concentration predicts progression in coronary artery stenosis
-
Asztalos, B. F., Batista, M., Horvath, K. V., Cox, C. E., Dallal, G. E., Morse, J. S., et al. (2003). Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler. Thromb. Vasc. Biol. 23, 847-852. doi: 10.1161/01.ATV.0000066133.32063.BB
-
(2003)
Arterioscler. Thromb. Vasc. Biol
, vol.23
, pp. 847-852
-
-
Asztalos, B.F.1
Batista, M.2
Horvath, K.V.3
Cox, C.E.4
Dallal, G.E.5
Morse, J.S.6
-
3
-
-
26244436291
-
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veterans affairs HDL intervention trial
-
Asztalos, B. F., Collins, D., Cupples, L. A., Demissie, S., Horvath, K. V., Bloomfield, H. E., et al. (2005). Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the veterans affairs HDL intervention trial. Arterioscler. Thromb. Vasc. Biol. 25, 2185-2191. doi: 10.1161/01.ATV.0000183727.90611.4f
-
(2005)
Arterioscler. Thromb. Vasc. Biol
, vol.25
, pp. 2185-2191
-
-
Asztalos, B.F.1
Collins, D.2
Cupples, L.A.3
Demissie, S.4
Horvath, K.V.5
Bloomfield, H.E.6
-
4
-
-
8344241096
-
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study
-
Asztalos, B. F., Cupples, L. A., Demissie, S., Horvath, K. V., Cox, C. E., Batista, M. C., et al. (2004). High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler. Thromb. Vasc. Biol. 24, 2181-2187. doi: 10.1161/01.ATV.0000146325.93749.a8
-
(2004)
Arterioscler. Thromb. Vasc. Biol
, vol.24
, pp. 2181-2187
-
-
Asztalos, B.F.1
Cupples, L.A.2
Demissie, S.3
Horvath, K.V.4
Cox, C.E.5
Batista, M.C.6
-
5
-
-
0141672118
-
HDL in atherosclerosis: actor or bystander?
-
Asztalos, B. F., and Schaefer, E. J. (2003a). HDL in atherosclerosis: actor or bystander? Atheroscler. Suppl. 4, 21-29. doi: 10.1016/S1567-5688(03)00006-0
-
(2003)
Atheroscler
, pp. 21-29
-
-
Asztalos, B.F.1
Schaefer, E.J.2
-
6
-
-
0037417229
-
High-density lipoprotein subpopulations in pathologic conditions
-
Asztalos, B. F., and Schaefer, E. J. (2003b). High-density lipoprotein subpopulations in pathologic conditions. Am. J. Cardiol. 91, 12E-17E. doi: 10.1016/S0002-9149(02)03383-0
-
(2003)
Am. J. Cardiol
, vol.91
, pp. 12E-17E
-
-
Asztalos, B.F.1
Schaefer, E.J.2
-
7
-
-
84863403878
-
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study
-
e1-e3
-
Ballantyne, C. M., Miller, M., Niesor, E. J., Burgess, T., Kallend, D., and Stein, E. A. (2012). Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am. Heart. J. 163, 515-521:e1-e3. doi: 10.1016/j.ahj.2011.11.017
-
(2012)
Am. Heart. J
, vol.163
, pp. 515-521
-
-
Ballantyne, C.M.1
Miller, M.2
Niesor, E.J.3
Burgess, T.4
Kallend, D.5
Stein, E.A.6
-
8
-
-
20944437770
-
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies. Apolipoprotein A-I metabolism, and fecal sterol excretion
-
Brousseau, M. E., Diffenderfer, M. R., Millar, J. S., Nartsupha, C., Asztalos, B. F., Welty, F. K., et al. (2005). Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies. Apolipoprotein A-I metabolism, and fecal sterol excretion. Arterioscler. Thromb. Vasc. Biol. 25, 1057-1064.
-
(2005)
Arterioscler. Thromb. Vasc. Biol
, vol.25
, pp. 1057-1064
-
-
Brousseau, M.E.1
Diffenderfer, M.R.2
Millar, J.S.3
Nartsupha, C.4
Asztalos, B.F.5
Welty, F.K.6
-
9
-
-
80053574090
-
Biological activities of HDL subpopulations and their relevance to cardiovascular disease
-
Camont, L., Chapman, M. J., and Kontush, A. (2011). Biological activities of HDL subpopulations and their relevance to cardiovascular disease. Trends Mol. Med. 17, 594-603. doi: 10.1016/j.molmed.2011.05.013
-
(2011)
Trends Mol. Med
, vol.17
, pp. 594-603
-
-
Camont, L.1
Chapman, M.J.2
Kontush, A.3
-
10
-
-
84888203299
-
Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol e?ux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities
-
Camont, L., Lhomme, M., Rached, F., Le Goff, W., Negre-Salvayre, A., Salvayre, R., et al. (2013). Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol e?ux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler. Thromb. Vasc. Biol. 33, 2715-2723. doi: 10.1161/ATVBAHA.113.301468
-
(2013)
Arterioscler. Thromb. Vasc. Biol
, vol.33
, pp. 2715-2723
-
-
Camont, L.1
Lhomme, M.2
Rached, F.3
Le Goff, W.4
Negre-Salvayre, A.5
Salvayre, R.6
-
11
-
-
66349083560
-
Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function
-
Davidson, W. S., Silva, R. A., Chantepie, S., Lagor, W. R., Chapman, M. J., and Kontush, A. (2009). Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler. Thromb. Vasc. Biol. 29, 870-876. doi: 10.1161/ATVBAHA.109.186031
-
(2009)
Arterioscler. Thromb. Vasc. Biol
, vol.29
, pp. 870-876
-
-
Davidson, W.S.1
Silva, R.A.2
Chantepie, S.3
Lagor, W.R.4
Chapman, M.J.5
Kontush, A.6
-
12
-
-
58749094271
-
High-density lipoprotein particle size and concentration and coronary risk
-
El Harchaoui, K., Arsenault, B. J., Franssen, R., Despres, J. P., Hovingh, G. K., Stroes, E. S., et al. (2009). High-density lipoprotein particle size and concentration and coronary risk. Ann. Intern. Med. 150, 84-93. doi: 10.7326/0003-4819-150-2-200901200-00006
-
(2009)
Ann. Intern. Med
, vol.150
, pp. 84-93
-
-
El Harchaoui, K.1
Arsenault, B.J.2
Franssen, R.3
Despres, J.P.4
Hovingh, G.K.5
Stroes, E.S.6
-
13
-
-
21544456070
-
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study
-
Festa, A., Williams, K., Hanley, A. J. G., Otvos, J. D., Goff, D. C., Wagenknecht, L. E., et al. (2005). Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the insulin resistance atherosclerosis study. Circulation 111, 3465-3472. doi: 10.1161/CIRCULATIONAHA.104.512079
-
(2005)
Circulation
, vol.111
, pp. 3465-3472
-
-
Festa, A.1
Williams, K.2
Hanley, A.J.G.3
Otvos, J.D.4
Goff, D.C.5
Wagenknecht, L.E.6
-
14
-
-
0037317156
-
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance
-
Garvey, W. T., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A., et al. (2003). Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes Metab. Res. Rev. 52, 453-462.
-
(2003)
Diabetes Metab. Res. Rev
, vol.52
, pp. 453-462
-
-
Garvey, W.T.1
Kwon, S.2
Zheng, D.3
Shaughnessy, S.4
Wallace, P.5
Hutto, A.6
-
15
-
-
12944296620
-
Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study
-
Goff, D. C. Jr., D'Agostino, R. B. Jr., Haffner, S. M., and Otvos, J. D. (2005). Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the insulin resistance atherosclerosis study. Metabolism 54, 264-270.
-
(2005)
Metabolism
, vol.54
, pp. 264-270
-
-
GoffJr., D.C.1
D'Agostino, R.B.2
Haffner, S.M.3
Otvos, J.D.4
-
16
-
-
84873524007
-
High-density lipoprotein proteomics: identifying new drug targets and biomarkers by understanding functionality
-
Gordon, S., Durairaj, A., Lu, J. L., and Davidson, W. S. (2010a). High-density lipoprotein proteomics: identifying new drug targets and biomarkers by understanding functionality. Curr. Cardiovasc. Risk Rep. 4, 1-8. doi: 10.1007/s12170-009-0069-9
-
(2010)
Curr. Cardiovasc. Risk Rep
, vol.4
, pp. 1-8
-
-
Gordon, S.1
Durairaj, A.2
Lu, J.L.3
Davidson, W.S.4
-
17
-
-
77957340934
-
Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography
-
Gordon, S. M., Deng, J., Lu, L. J., and Davidson, W. S. (2010b). Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography. J. Proteome Res. 9, 5239-5249. doi: 10.1021/pr100520x
-
(2010)
J. Proteome Res
, vol.9
, pp. 5239-5249
-
-
Gordon, S.M.1
Deng, J.2
Lu, L.J.3
Davidson, W.S.4
-
18
-
-
66349096057
-
The HDL proteome: a marker - and perhaps mediator - of coronary artery disease
-
Heinecke, J. W. (2009). The HDL proteome: a marker - and perhaps mediator - of coronary artery disease. J. Lipid Res. 50, S167-S171. doi: 10.1194/jlr. R800097-JLR200
-
(2009)
J. Lipid Res
, vol.50
, pp. S167-S171
-
-
Heinecke, J.W.1
-
19
-
-
84938936214
-
HDL re-examined
-
Hovingh, G. K., Rader, D. J., and Hegele, R. A. (2015). HDL re-examined. Curr. Opin. Lipidol. 26, 127-132. doi: 10.1097/MOL.0000000000000161
-
(2015)
Curr. Opin. Lipidol
, vol.26
, pp. 127-132
-
-
Hovingh, G.K.1
Rader, D.J.2
Hegele, R.A.3
-
20
-
-
33750804460
-
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
-
Jeyarajah, E. J., Cromwell, W. C., and Otvos, J. D. (2006). Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin. Lab. Med. 26, 847-870. doi: 10.1016/j.cll.2006.07.006
-
(2006)
Clin. Lab. Med
, vol.26
, pp. 847-870
-
-
Jeyarajah, E.J.1
Cromwell, W.C.2
Otvos, J.D.3
-
21
-
-
33644861577
-
Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study
-
Kathiresan, S., Otvos, J. D., Sullivan, L. M., Keyes, M. J., Schaefer, E. J., Wilson, P. W., et al. (2006). Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 113, 20-29. doi: 10.1161/CIRCULATIONAHA.105.567107
-
(2006)
Circulation
, vol.113
, pp. 20-29
-
-
Kathiresan, S.1
Otvos, J.D.2
Sullivan, L.M.3
Keyes, M.J.4
Schaefer, E.J.5
Wilson, P.W.6
-
22
-
-
33644608784
-
Antiatherogenic small, dense HDL - guardian angel of the arterial wall? Nat
-
Kontush, A., and Chapman, M. J. (2006a). Antiatherogenic small, dense HDL - guardian angel of the arterial wall? Nat. Clin. Pract. Cardiovasc. Med. 3, 144-153. doi: 10.1038/ncpcardio0500
-
(2006)
Clin. Pract. Cardiovasc. Med
, vol.3
, pp. 144-153
-
-
Kontush, A.1
Chapman, M.J.2
-
23
-
-
33748681287
-
Functionally defective HDL: a new therapeutic target at the crossroads of dyslipidemia, inflammation and atherosclerosis
-
Kontush, A., and Chapman, M. J. (2006b). Functionally defective HDL: a new therapeutic target at the crossroads of dyslipidemia, inflammation and atherosclerosis. Pharmacol. Rev. 3, 342-374. doi: 10.1124/pr.58.3.1
-
(2006)
Pharmacol. Rev
, vol.3
, pp. 342-374
-
-
Kontush, A.1
Chapman, M.J.2
-
24
-
-
84863232685
-
Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib
-
Krauss, R. M., Wojnooski, K., Orr, J., Geaney, J. C., Pinto, C. A., Liu, Y., et al. (2012). Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib. J. Lipid Res. 53, 540-547. doi: 10.1194/jlr. M018010
-
(2012)
J. Lipid Res
, vol.53
, pp. 540-547
-
-
Krauss, R.M.1
Wojnooski, K.2
Orr, J.3
Geaney, J.C.4
Pinto, C.A.5
Liu, Y.6
-
25
-
-
0036061717
-
Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study
-
Kuller, L., Arnold, A., Tracy, R., Otvos, J., Burke, G., Psaty, B., et al. (2002). Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 22, 1175-1180. doi: 10.1161/01.ATV.0000022015.97341.3A
-
(2002)
Arterioscler. Thromb. Vasc. Biol
, vol.22
, pp. 1175-1180
-
-
Kuller, L.1
Arnold, A.2
Tracy, R.3
Otvos, J.4
Burke, G.5
Psaty, B.6
-
26
-
-
35248829949
-
Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome
-
Kuller, L. H., Grandits, G., Cohen, J. D., Neaton, J. D., Prineas, R., and Multiple Risk Factor Intervention Trial Research Group (2007). Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis 195, 122-128.
-
(2007)
Atherosclerosis
, vol.195
, pp. 122-128
-
-
Kuller, L.H.1
Grandits, G.2
Cohen, J.D.3
Neaton, J.D.4
Prineas, R.5
-
27
-
-
33748038025
-
Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease
-
Kuvin, J. T., Dave, D. M., Sliney, K. A., Mooney, P., Patel, A. R., Kimmelstiel, C. D., et al. (2006). Effects of extended-release niacin on lipoprotein particle size, distribution, and inflammatory markers in patients with coronary artery disease. Am. J. Cardiol. 98, 743-745. doi: 10.1016/j.amjcard.2006.04.011
-
(2006)
Am. J. Cardiol
, vol.98
, pp. 743-745
-
-
Kuvin, J.T.1
Dave, D.M.2
Sliney, K.A.3
Mooney, P.4
Patel, A.R.5
Kimmelstiel, C.D.6
-
28
-
-
40749133780
-
Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women
-
Lamon-Fava, S., Herrington, D. M., Reboussin, D. M., Sherman, M., Horvath, K. V., Cupples, L. A., et al. (2008). Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 28, 575-579. doi: 10.1161/ATVBAHA.107.157123
-
(2008)
Arterioscler. Thromb. Vasc. Biol
, vol.28
, pp. 575-579
-
-
Lamon-Fava, S.1
Herrington, D.M.2
Reboussin, D.M.3
Sherman, M.4
Horvath, K.V.5
Cupples, L.A.6
-
29
-
-
84899592699
-
Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients
-
Le, N. A., Jin, R., Tomassini, J. E., Tershakovec, A. M., Neff, D. R., and Wilson, P. W. (2013). Changes in lipoprotein particle number with ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidemic patients. J. Am. Heart. Assoc. 2:e000037. doi: 10.1161/JAHA.113.000037
-
(2013)
J. Am. Heart. Assoc
, vol.2
-
-
Le, N.A.1
Jin, R.2
Tomassini, J.E.3
Tershakovec, A.M.4
Neff, D.R.5
Wilson, P.W.6
-
30
-
-
84864767131
-
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis)
-
Mackey, R. H., Greenland, P., Goff, D. C. Jr., Lloyd-Jones, D., Sibley, C. T., and Mora, S. (2012). High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (Multi-Ethnic Study of Atherosclerosis). J. Am. Coll. Cardiol. 60, 508-516. doi: 10.1016/j.jacc.2012.03.060
-
(2012)
J. Am. Coll. Cardiol
, vol.60
, pp. 508-516
-
-
Mackey, R.H.1
Greenland, P.2
GoffJr., D.C.3
Lloyd-Jones, D.4
Sibley, C.T.5
Mora, S.6
-
31
-
-
84925310644
-
Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy
-
Mallol, R., Amigo, N., Rodriguez, M. A., Heras, M., Vinaixa, M., Plana, N., et al. (2015). Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J. Lipid Res. 56, 737-746. doi: 10.1194/jlr. D050120
-
(2015)
J. Lipid Res
, vol.56
, pp. 737-746
-
-
Mallol, R.1
Amigo, N.2
Rodriguez, M.A.3
Heras, M.4
Vinaixa, M.5
Plana, N.6
-
32
-
-
84921803832
-
HDL particle number measured on the Vantera(R), the first clinical NMR analyzer
-
Matyus, S. P., Braun, P. J., Wolak-Dinsmore, J., Saenger, A. K., Jeyarajah, E. J., Shalaurova, I., et al. (2015). HDL particle number measured on the Vantera(R), the first clinical NMR analyzer. Clin. Biochem. 48, 148-155. doi: 10.1016/j.clinbiochem.2014.11.017
-
(2015)
Clin. Biochem
, vol.48
, pp. 148-155
-
-
Matyus, S.P.1
Braun, P.J.2
Wolak-Dinsmore, J.3
Saenger, A.K.4
Jeyarajah, E.J.5
Shalaurova, I.6
-
33
-
-
84884322622
-
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy
-
Mora, S., Glynn, R. J., and Ridker, P. M. (2013). High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation 128, 1189-1197. doi: 10.1161/CIRCULATIONAHA.113.002671
-
(2013)
Circulation
, vol.128
, pp. 1189-1197
-
-
Mora, S.1
Glynn, R.J.2
Ridker, P.M.3
-
34
-
-
61849110301
-
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
-
Mora, S., Otvos, J. D., Rifai, N., Rosenson, R. S., Buring, J. E., and Ridker, P. M. (2009). Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119, 931-939. doi: 10.1161/CIRCULATIONAHA.108.816181
-
(2009)
Circulation
, vol.119
, pp. 931-939
-
-
Mora, S.1
Otvos, J.D.2
Rifai, N.3
Rosenson, R.S.4
Buring, J.E.5
Ridker, P.M.6
-
35
-
-
34247159573
-
LDL particle subclasses. LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)
-
Mora, S., Szklo, M., Otvos, J. D., Greenland, P., Psaty, B. M., Goff, D. C., et al. (2007). LDL particle subclasses. LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 192, 211-217.
-
(2007)
Atherosclerosis
, vol.192
, pp. 211-217
-
-
Mora, S.1
Szklo, M.2
Otvos, J.D.3
Greenland, P.4
Psaty, B.M.5
Goff, D.C.6
-
36
-
-
73949114559
-
Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk
-
Musunuru, K., Orho-Melander, M., Caulfield, M. P., Li, S., Salameh, W. A., Reitz, R. E., et al. (2009). Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler. Thromb. Vasc. Biol. 29, 1975-1980. doi: 10.1161/ATVBAHA.109.190405
-
(2009)
Arterioscler. Thromb. Vasc. Biol
, vol.29
, pp. 1975-1980
-
-
Musunuru, K.1
Orho-Melander, M.2
Caulfield, M.P.3
Li, S.4
Salameh, W.A.5
Reitz, R.E.6
-
37
-
-
0036210564
-
Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy
-
Otvos, J. D. (2002). Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. Clin. Lab. 48, 171-180.
-
(2002)
Clin. Lab.
, vol.48
, pp. 171-180
-
-
Otvos, J.D.1
-
38
-
-
33645741889
-
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
-
Otvos, J. D., Collins, D., Freedman, D. S., Shalaurova, I., Schaefer, E. J., Mcnamara, J. R., et al. (2006). Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation 113, 1556-1563. doi: 10.1161/CIRCULATIONAHA.105.565135
-
(2006)
Circulation
, vol.113
, pp. 1556-1563
-
-
Otvos, J.D.1
Collins, D.2
Freedman, D.S.3
Shalaurova, I.4
Schaefer, E.J.5
Mcnamara, J.R.6
-
39
-
-
85027944383
-
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study
-
Parish, S., Offer, A., Clarke, R., Hopewell, J. C., Hill, M. R., Otvos, J. D., et al. (2012). Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation 125, 2469-2478. doi: 10.1161/CIRCULATIONAHA.111.073684
-
(2012)
Circulation
, vol.125
, pp. 2469-2478
-
-
Parish, S.1
Offer, A.2
Clarke, R.3
Hopewell, J.C.4
Hill, M.R.5
Otvos, J.D.6
-
40
-
-
84887963089
-
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease
-
Riwanto, M., and Landmesser, U. (2013). High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease. J. Lipid Res. 54, 3227-3243. doi: 10.1194/jlr. R037762
-
(2013)
J. Lipid Res
, vol.54
, pp. 3227-3243
-
-
Riwanto, M.1
Landmesser, U.2
-
41
-
-
79952222810
-
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events
-
Rosenson, R. S., Brewer, H. B. Jr., Chapman, M. J., Fazio, S., Hussain, M. M., Kontush, A., et al. (2011). HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events. Clin. Chem. 57, 392-410. doi: 10.1373/clinchem.2010.155333
-
(2011)
Clin. Chem
, vol.57
, pp. 392-410
-
-
Rosenson, R.S.1
Brewer, H.B.2
Chapman, M.J.3
Fazio, S.4
Hussain, M.M.5
Kontush, A.6
-
42
-
-
0037099259
-
Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial
-
Rosenson, R. S., Otvos, J. D., and Freedman, D. S. (2002). Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am. J. Cardiol. 90, 89-94. doi: 10.1016/S0002-9149(02)02427-X
-
(2002)
Am. J. Cardiol
, vol.90
, pp. 89-94
-
-
Rosenson, R.S.1
Otvos, J.D.2
Freedman, D.S.3
-
43
-
-
66549089455
-
Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study
-
Rosenson, R. S., Otvos, J. D., and Hsia, J. (2009). Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study. Diabetes Care 32, 1087-1091. doi: 10.2337/dc08-1681
-
(2009)
Diabetes Care
, vol.32
, pp. 1087-1091
-
-
Rosenson, R.S.1
Otvos, J.D.2
Hsia, J.3
-
44
-
-
36348941677
-
Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction
-
Schaefer, E. J., and Asztalos, B. F. (2007a). Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction. Am. J. Cardiol. 100, S25-S31. doi: 10.1016/j.amjcard.2007.08.010
-
(2007)
Am. J. Cardiol
, vol.100
, pp. S25-S31
-
-
Schaefer, E.J.1
Asztalos, B.F.2
-
45
-
-
34250159840
-
Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction?
-
Schaefer, E. J., and Asztalos, B. F. (2007b). Where are we with high-density lipoprotein raising and inhibition of cholesteryl ester transfer for heart disease risk reduction? Curr. Opin. Cardiol. 22, 373-378. doi: 10.1097/HCO.0b013e3281fbd3c7
-
(2007)
Curr. Opin. Cardiol
, vol.22
, pp. 373-378
-
-
Schaefer, E.J.1
Asztalos, B.F.2
-
46
-
-
84884138140
-
Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
-
Shah, A. S., Tan, L., Long, J. L., and Davidson, W. S. (2013). Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond. J. Lipid Res. 54, 2575-2585. doi: 10.1194/jlr. R035725
-
(2013)
J. Lipid Res
, vol.54
, pp. 2575-2585
-
-
Shah, A.S.1
Tan, L.2
Long, J.L.3
Davidson, W.S.4
-
47
-
-
38749102779
-
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies
-
van der Steeg, W. A., Holme, I., Boekholdt, S. M., Larsen, M. L., Lindahl, C., Stroes, E. S., et al. (2008). High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J. Am. Coll. Cardiol. 51, 634-642. doi: 10.1016/j.jacc.2007.09.060
-
(2008)
J. Am. Coll. Cardiol
, vol.51
, pp. 634-642
-
-
van der Steeg, W.A.1
Holme, I.2
Boekholdt, S.M.3
Larsen, M.L.4
Lindahl, C.5
Stroes, E.S.6
|